Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07781319 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT07781319 · ClinicalTrials.gov record · last posted 2026-08-24

Early Gastric Cancer in the Spanish EURECCA Registry

StatusCompleted
PhaseNot specified
Started2014-01
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
Early gastric cancer (EGC) is increasingly diagnosed in Western countries; however, important differences remain with Eastern populations regarding staging accuracy, treatment strategies, and the risk of lymph node metastasis. While endoscopic resection is the standard treatment for selected EGC in Asia based on well-established criteria, the applicability of these criteria to Western populations remains uncertain because of differences in epidemiology, clinical practice, and pathological characteristics. This multicenter retrospective cohort study, based on the Spanish EURECCA Registry, aims to evaluate the concordance between clinical and pathological staging, determine the real incidence and predictors of lymph node metastasis in patients with pathological T1 gastric cancer, assess the applicability of standard and expanded Asian endoscopic resection criteria in a Western cohort, and analyze long-term oncological outcomes, including recurrence and overall survival.
Trial Details
NCT Number NCT07781319
Lead Sponsor Corporacion Parc Tauli
Collaborators: Spanish EURECCA Group for Esophagogastric Surgery (GEECEG)
Conditions Early Gastric Cancer, Gastric Adenocarcinoma
Enrollment 600 participants
Start Date 2014-01
Primary Completion 2022-12 (estimated)
Study Completion 2022-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-24